FDA Approves Oculus' Microcyn Skin And Wound HydroGel

March 10, 2010 10:50 AM |

The Food and Drug Administration approved Oculus Innovative Sciences Inc.'s (Nasdaq: OCLS) Microcyn Skin and Wound HydroGel. The stock price jumped $1.07 to $2.88.

Tags:

Search

About this Entry

This page contains a single entry by published on March 10, 2010 10:50 AM.

Abbott Offers $450 Million For Facet Biotech was the previous entry in this blog.

Taiwan To Review Sale Of AIG's Taiwan Unit is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12